St1 Biokraft secures €260M debt package from eight-bank European syndicate
What's the deal? Nordic biomethane producer St1 BiokraftDealroom has a profile for this one. Try Dealroom → has secured a €260 million corporate financing package from a syndicate of eight European banks. The funds will go toward building new greenfield biomethane production plants and expanding its network of liquefied biomethane (LBG) filling stations across the Nordics and Northern Europe.
The syndicate includes ABN AmroDealroom has a profile for this one. Try Dealroom →, DNBDealroom has a profile for this one. Try Dealroom →, INGDealroom has a profile for this one. Try Dealroom →, NordeaDealroom has a profile for this one. Try Dealroom →, OP BankDealroom has a profile for this one. Try Dealroom →, RabobankDealroom has a profile for this one. Try Dealroom →, SpareBank 1Dealroom has a profile for this one. Try Dealroom →, and SwedbankDealroom has a profile for this one. Try Dealroom →. ING served as sole financial adviser and facility agent.
St1 Biokraft runs an end-to-end model covering feedstock sourcing, production, logistics, distribution, and sales. It targets heavy transport, maritime, and industrial customers. The company is majority-owned by HitecVisionDealroom has a profile for this one. Try Dealroom → and St1 Group.
Why now? The company has ambitious growth targets: 3 TWh of own biomethane production by 2030 and 6 TWh in sales and distribution. That plan requires roughly €1 billion in total investment across biogas production and distribution networks in the Nordic region — making this €260 million package a critical first tranche.
Chief executive Miika Johansson called the deal "a clear validation" of the company's strategy and said biomethane is "increasingly recognised as a scalable and investable asset class."
What could go wrong? Biomethane remains a niche fuel compared with electrification and hydrogen. Scaling production to 3 TWh depends on securing feedstock supply, permits, and offtake agreements across multiple Nordic markets — none of which is guaranteed. A downturn in political support or subsidy frameworks could also slow deployment.
The signal: Dealroom classifies St1 Biokraft as a "breakout" stage company, yet it has assembled a lending syndicate stacked with major Nordic and European corporate banks — DNB, Nordea, Swedbank, OP, and Rabobank among them — typically reserved for far more mature infrastructure plays. That level of institutional buy-in suggests biomethane is crossing the threshold from niche green fuel to bankable asset class, particularly for hard-to-electrify sectors like heavy freight and maritime where few credible alternatives exist at scale.
Read more: Bioenergy Insight
